Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients. Click here to read why ASMB is a Buy.
Assembly Biosciences: Positive Data Of ABI-5366 Brings 2 Fall Program Catalysts (ASMB)
Seeking Alpha Stock3 hrs ago
36
The Cut
Raw Story
America News
CNN Health
KSNB Local4 Central Nebraska
The Outer Banks Voice Community
AlterNet
Omak Okanogan County Chronicle
The US Sun Health
Essentiallysports Football